CSIMarket
 
Oaktree Acquisition Corp Iii Life Sciences  (NASDAQ: OACCU)
    Sector • Financial    Industry • Blank Checks
   Industry • Blank Checks
   Sector • Financial
 

Oaktree Acquisition Iii Life Sciences's Customers Performance

OACCU



 
OACCU's Source of Revenues

• List of OACCU Customers




for the same period Oaktree Acquisition Corp Iii Life Sciences

• List of OACCU Customers





Oaktree Acquisition Iii Life Sciences's Comment on Sales, Marketing and Customers



Oaktree serves clients including pension plans, insurance companies, endowments, foundations, and sovereign wealth funds. The firm operates across various asset classes and market sectors, focusing on control investing, listed equities, and alternative investment strategies. Oaktree has experience with special purpose acquisition companies (SPACs), particularly in healthcare, with prior de-SPAC acquisitions of Hims & Hers Health, Inc. and Alvotech. The firm maintains relationships with banks, financial institutions, brokers, advisors, and attorneys to access selective investment opportunities. Oaktree's Life Sciences investment platform, co-led by Chairman Dr. Aman Kumar, has committed approximately $6.2 billion across 54 life sciences investments since 2013, concentrating on private lending in the life sciences sector.





Oaktree Acquisition Iii Life Sciences’s Comment on Sales, Marketing and Customers


Oaktree serves clients including pension plans, insurance companies, endowments, foundations, and sovereign wealth funds. The firm operates across various asset classes and market sectors, focusing on control investing, listed equities, and alternative investment strategies. Oaktree has experience with special purpose acquisition companies (SPACs), particularly in healthcare, with prior de-SPAC acquisitions of Hims & Hers Health, Inc. and Alvotech. The firm maintains relationships with banks, financial institutions, brokers, advisors, and attorneys to access selective investment opportunities. Oaktree's Life Sciences investment platform, co-led by Chairman Dr. Aman Kumar, has committed approximately $6.2 billion across 54 life sciences investments since 2013, concentrating on private lending in the life sciences sector.








OACCU's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Oaktree Acquisition Corp Iii Life Sciences 211.17 0.00 6.89 -
SUBTOTAL 0.00 0.00 0.00 -

Sources: Oaktree Acquisition Corp Iii Life Sciences’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Oaktree Acquisition Corp Iii Life Sciences’s corporate clients.
For your research, we’ve provided 9 tables on Oaktree Acquisition Corp Iii Life Sciences corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.